XML 89 R61.htm IDEA: XBRL DOCUMENT v3.22.4
Subsequent events (Details) - Subsequent events - Collaboration agreement with AbbVie
$ in Millions
Jan. 04, 2023
USD ($)
Subsequent Event [Line Items]  
Research term (in months) 66 months
Upfront payment $ 30.0
Additional platform access payments $ 70.0
Anniversary of first commerical sale (in years) 10 years
Maximum  
Subsequent Event [Line Items]  
Additional platform access payments $ 70.0
Development and commercial sale milestone receivable per target 120.0
Sales based milestone based on achievement 150.0
Potentially eligible amount receivable $ 2.8